Phio Pharmaceuticals (PHIO) Other financing activities (2012 - 2025)

Phio Pharmaceuticals (PHIO) has 10 years of Other financing activities data on file, last reported at $2.8 million in Q4 2025.

• Quarterly Other financing activities rose 109.07% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$738000.0 (down 107.03% YoY) and the FY2025 annual result came in at $5.8 million, up 43.8% from the prior year.
• Other financing activities improved to $2.8 million in Q4 2025, from $200000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $6.5 million in Q1 2025 to a low of -$3.8 million in Q2 2025.
• A 3-year average of $1.2 million and a median of $778000.0 in 2024 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 109.07% in 2025, down 92.44% in 2025.
• Tracing PHIO's Other financing activities over 3 years: stood at -$25000.0 in 2022, then surged by 5524.0% to $1.4 million in 2024, then soared by 109.07% to $2.8 million in 2025.
• The last three Other financing activities figures came in at $2.8 million (Q4 2025), $200000.0 (Q3 2025), and -$3.8 million (Q2 2025), per Business Quant data.